Similarly, negativity for neuroendocrine markers (Syn, CgA, and CD56) excludes a pancreatic neuroendocrine tumor (39).​​ CD34 negativity​​ helps exclude a ​​solitary fibrous tumor (40). This evidence concerns the gene CGA and pancreatic neuroendocrine tumor.